1. Market Research
  2. > Global Biobetters Trends Industry

Global Biobetters Trends Industry

  • January 2014
  • -
  • Global Industry Analysts
  • -
  • 14 pages

The report analyzes and presents an overview of Biobetters market worldwide. "Biobetters or Biosuperiors are novel molecules derived from successful, approved biologic products that have been customized to enhance its overall efficacy. The primary characteristics targeted by these applicants include extended half-life in human body, improved bioavailability, lower immunogenicity, higher purity, and fewer side-effects. These molecules contain the same active ingredients such as antibodies to target the same protein, but feature different chemical or molecular properties than the original drug."

The report further discusses about applications, future prospects, and comparison of biobetters with originator drugs and biosimilars along with the strategic industry activities of major companies worldwide. In addition, major companies operating in the Biobetters arena worldwide including Amgen Inc., Cantab Biopharmaceuticals Ltd., Crucell NV, GreenCross Corporation, Hanmi Pharm Co. Ltd., Medgenics Inc., PharmaEssentia Corporation, Polytherics Ltd., SynBio LLC, Teva Pharmaceutical Industries Ltd., Xencor Inc., and others are profiled.

Table Of Contents

Global Biobetters Trends Industry


A Prelude

Biobetters - A Better Bet

Originator Drugs vs. Biobetters

Biosimilars vs. Biobetters


An Evolution from Biotherapeutics to Biologics

Biobetter - The Gold Rush

Biotechnology Start-ups Focus on Biobetter Route

US Regulatory Scenario


Synthon Takes Over Key Platforms of Biolex Therapeutics

Xencor Signs Agreement with Boehringer Ingelheim

Catalent Pharma Solutions Inks Agreement with Aptuit

Compass Biotechnologies Establishes New Subsidiaries

Human Stem Cells Institute Announces SynBio Project

Lancaster Laboratories Enters into Partnership with BioAzure Technologies

Momenta Pharmaceuticals Inks Agreement with Virdante Pharmaceuticals

PolyTherics Inks Agreement with DSM BioSolutions

Watson Pharmaceuticals Acquires Eden Biopharm Group


Amgen, Inc. (USA)

Bolder BioTechnology, Inc. (USA)

Boryung Pharmaceutical Co., Ltd. (Korea)

Caliber Biotherapeutics LLC (USA)

Cantab Biopharmaceuticals Ltd. (UK)

Celtrion, Inc. (Korea)

ChromaCon AG (Switzerland)

Crucell NV (The Netherlands)

F. Hoffmann-La Roche Ltd. (Switzerland)

Flamel Technologies SA (France)

Genentech, Inc. (USA)

Glycotope GmbH (Germany)

GreenCross Corporation (Korea)

HanAll BioPharma Co., Ltd. (Korea)

Hanmi Pharm Co., Ltd. (Korea)

Harvest Moon Pharmaceuticals USA, Inc. (USA)

Medgenics, Inc. (USA)

OPKO Health Inc. (USA)

Pfizer, Inc. (USA)

PharmaEssentia Corporation (Taiwan)

Pieris AG (Germany)

Polytherics Ltd. (UK)

rEVO Biologics (USA)

Sutro Biopharma, Inc. (USA)

SynBio LLC (Russia)

Synthon (The Netherlands)

Teva Pharmaceutical Industries Ltd. (Israel)

Theramyt Novobiologics Pvt., Ltd. (India)

Vitapharm Technology Development Co., Ltd. (China)

Xencor, Inc. (USA)


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.